KCNH2 and familial long QT syndrome: The need for improved LQTS pharmacotherapy is further supported by the difficulties surrounding hERG modulation, as several clinically-used drugs can cause drug-induced LQTS by blocking hERG and suppressing IKr (Vandenberg et al., 2012; Kalyaanamoorthy and Barakat, 2018).